Stock exchange releases
- The Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectus – Mar 17, 2025
- Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US – Mar 17, 2025
- Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki – Mar 12, 2025